objective response frequency was only 5 % in the initial 20 patients receiving acco treatment compared to a response frequency of 28 % ( 7 % complete ) in the 28 patients receiving cisplatinum in the pacco treatment arm ( p less than 0.06 ) .
C0008838
cisplatinum
C0056274
pacco